Last reviewed · How we verify

NCT03311685

Vaginal Tactile Imaging for the Assessment of Pelvic Organ Prolapse Repair Efficiency

Completed NA Last updated 27 July 2020
What this trial tests

NA trial testing vaginal tactile imager in Pelvic Organ Prolapse in 30 participants. Completed in 20 July 2020.

Timeline
1 August 2018
Primary endpoint
30 June 2020
20 July 2020

Quick facts

Lead sponsorRambam Health Care Campus
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment30
Start date1 August 2018
Primary completion30 June 2020
Estimated completion20 July 2020
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Rambam Health Care Campus — full company profile →

Who can join

Adults 18 to 75, female only, with Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Female patients with POP will be evaluated for vaginal elasticity using vaginal tactile imaging both before and after surgery for the repair of the POP. Surgical repair will be performed by a single surgeon who will perform either a laparoscopic or vaginal repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pelvic Organ Prolapse

Currently open trials in the same condition.

Other Rambam Health Care Campus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03311685.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing